iStent Inject New Enrollment Post-Approval Study

NCT04624698 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 358

Last updated 2024-02-23

No results posted yet for this study

Summary

Study to evaluate the rate of clinically relevant complications associated with iStent inject placement in the post-market setting.

Conditions

Interventions

DEVICE

iStent Inject Implantation

Subjects will be implanted with the iStent Injection Micro-Bypass device

Sponsors & Collaborators

  • Glaukos Corporation

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-22
Primary Completion
2026-05-31
Completion
2026-05-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04624698 on ClinicalTrials.gov